153
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Progesterone and not estrogens or androgens causes breast cancer

ORCID Icon &
Pages 217-222 | Received 03 Nov 2023, Accepted 21 Nov 2023, Published online: 10 Jan 2024
 

Acknowledgements

The authors thank Amanda Prowse and Jan Egberts (T4C Communications, Hilversum, The Netherlands) for their valuable editorial support. Data sharing is not applicable to this article as no new data were created or analyzed in this study.

Potential conflict of interest

H. J. T. Coelingh Bennink is President of Pantarhei Oncology (subsidiary of Pantarhei Bioscience), the company developing the fetal estrogen estetrol for the treatment of advanced breast and prostate cancer, but this is outside the scope of the present letter. F. Z. Stanczyk has no conflict of interest.

Source of funding

None.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.